In comparison to the patients without depression symptoms (20.61 ± 14.09) (p = 0.00003). The study also shows that negative symptoms of treatment measured by the EORTC QLQ-BR23 scale to assess the quality of life of women with breast cancer were statistically more severe among patients after mastectomy who suffered from depression (33.90 ± 18.63) The results obtained are shown in Table V. Statistical analyses were performed basing on the STATISTICA 8.0 program, assuming the significance level of p 0.05). This tool allows you to assess the strength of each depressive symptom such as lowered mood, anxiety, and fear, low self-esteem, loss of the ability to experience happiness, feeling of guilt, expectation of punishment, self-dislike, suicidal thoughts, tearfulness, feelings of anxiety and the loss of libido. It consists of 21 points evaluated on a 0 to 3 scale. The Beck Depression Inventory (BDI) is a self-assessment scale. It includes the following subscales: adverse symptoms of treatment, body image, sexual functioning, symptoms from the upper limb and from the breast and single points: the perspective of life, sexual satisfaction and stress associated with the loss of hair. The EORTC QLQ-BR23 scale is used to determine the quality of life of women with breast cancer. It is an international, standardized research tool consisting of 5 functional scales, three symptomatic scales and the scale to assess the overall quality of life (QoL) and six single points. The scale of the EORTC QLQ-C30 is used to determine the quality of life of people suffering from cancer. Material and methodsIn the paper, there was applied an assessment method with the use of numerical scale techniques with three tools: a research questionnaire EORTC QLQ-C30 (version 3.0) and EORTC QLQ-BR23 as well as the Beck Depression Inventory (BDI). The aim of this study was to determine how mastectomy and breast reconstruction affect the psychological state and quality of life of women who underwent the above-mentioned surgeries. One of the most frequently used screening questionnaires to assess the risk of depression is the Beck’s questionnaire. To achieve this there are screening scales to register symptoms of depression, anxiety and PTSD (post-traumatic stress disorder). The indispensable part of the assessment of quality of life is the assessment of mental health. For women with breast cancer, a separate questionnaire (QLQ-BR23) was developed. In recent literature, the most widely used questionnaire to assess malignant cancer patients’ quality of life is EORTC QLQ-C30 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-30). To assess coping with cancer there are a number of tools constructed to assess the quality of life. As for malignant disease, it is important to treat it, but the quality of life is also crucial. More and more women do not have to undergo mastectomy and as a result use a breast prosthesis, but have the ability to have the breast reconstructed. The diagnosis of cancer usually causes a sense of anxiety about the outcome of treatment and complications.īreast cancer is a specific situation for women because it is associated not only with the fact that most women treat cancer as incurable disease but also with the need to undergo treatment which includes mastectomy and long-term systemic treatment including surgery, chemotherapy, radiotherapy, and hormone therapy. IntroductionBreast cancer affects 1 out of 12 women in Poland and is the cause of 13% of deaths from cancer among women.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |